Increased microneedle-mediated transdermal delivery of tetramethylpyrazine to the brain, combined with borneol and iontophoresis, for MCAO prevention

被引:18
|
作者
Xiao, Sirui [1 ]
Yan, Yulu [1 ]
Zhao, Jihui [1 ]
Zhang, Yongtai [1 ]
Feng, Nianping [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Dept Pharmaceut Sci, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Permeation; Percutaneous; Transdermal enhancer; Middle cerebral artery occlusion; DRUG-DELIVERY; REPERFUSION INJURY; BARRIER; HYDROCHLORIDE; ISCHEMIA; COMBINATION; LIPOSOMES; PHOSPHATE; STROKE; VIVO;
D O I
10.1016/j.ijpharm.2019.118962
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this research was to improve transdermal delivery and distribution of tetramethylpyrazine (TMP) in the brain, by adding borneol (BN) and iontophoresis (ITP), and using microneedles (MN), to prevent middle cerebral artery occlusion (MCAO). BN was encapsulated into sulfobutylated-beta-cyclodextrin (BN-SBE-beta-CD), and then dispersed together with TMP. Four delivery groups were tested: passive (with no ITP and MN), ITP, MN, and MN combined with ITP (MN-ITP). In vitro transdermal fluxes of the drugs in those groups and in that corresponding order were 79.12 +/- 14.5, 395.43 +/- 12.37, 319.16 +/- 29.99, and 1018.07 +/- 108.92 mu g/cm(2) (for TMP), and 39.34 +/- 1.31, 202.81 +/- 53.56, 715.47 +/- 75.52, and 1088.60 +/- 53.90 mu g/cm(2) (for BN), respectively, which indicated that the use of MN-ITP greatly enhanced transdermal TMP and BN delivery compared to the other groups. The AUC(0-t) for the combined use of TMP and BN drugs was measured using two in vivo studies, cutaneous microdialysis and pharmacodynamic, yielding increased folds of 3.69 and 1.98 in ITP, 6.05 and 2.73 in MN, and 12.43 and 7.47 in MN-ITP groups, respectively, as compared to those in the passive group. In addition, the combined use of TMP and BN increased TMP distribution in the heart and the brain, indicated by TMP C-max of 1.76- and 1.59-fold higher (p < 0.05), and TMP AUC(0-t) of 1.50 times and 1.19-fold higher (p < 0.01), than with administration of TMP in absence of BN, respectively. The brain infarction area and IL-beta expression in the MCAO rat were significantly decreased in the MN-ITP group, compared with the control group (p < 0.05). In conclusion, combination of MN and ITP resulted in a synergistic enhancement of transdermal delivery and distribution of TMP in the brain, when in combination with BN, thereby significantly decreasing the infarct volumes and improving the neurological scores of MCAO.
引用
收藏
页数:10
相关论文
共 25 条
  • [11] Microneedle-Mediated Transdermal Delivery of Genetic Materials, Stem Cells, and Secretome: An Update and Progression
    Nainggolan, Avelia Devina Calista
    Anjani, Qonita Kurnia
    Hartrianti, Pietradewi
    Donnelly, Ryan F.
    Kurniawan, Arief
    Ramadon, Delly
    PHARMACEUTICS, 2023, 15 (12)
  • [12] Effect of Lipophilicity on Microneedle-Mediated Iontophoretic Transdermal Delivery Across Human Skin In Vitro
    Pawar, Kasturi R.
    Smith, Forrest
    Kolli, Chandra Sekhar
    Babu, R. Jayachandra
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (10) : 3784 - 3791
  • [13] Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
    Malek-Khatabi, Atefeh
    Sadat Razavi, Malihe
    Abdollahi, Alyeh
    Rahimzadeghan, Milad
    Moammeri, Fatemeh
    Sheikhi, Mojgan
    Tavakoli, Mohamadreza
    Rad-Malekshahi, Mazda
    Faraji Rad, Zahra
    BIOMATERIALS SCIENCE, 2023, 11 (16) : 5390 - 5409
  • [14] Microneedle-mediated transdermal delivery of nanostructured lipid carriers for alkaloids from Aconitum sinomontanum
    Guo, Teng
    Zhang, Yongtai
    Li, Zhe
    Zhao, Jihui
    Feng, Nianping
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 (08) : 1541 - 1551
  • [15] Mathematical modelling of microneedle-mediated transdermal delivery of drug nanocarriers into skin tissue and circulatory system
    Newell, Ben
    Zhan, Wenbo
    JOURNAL OF CONTROLLED RELEASE, 2023, 360 : 447 - 467
  • [16] Microneedle-mediated transdermal delivery of N-acetyl cysteine as a potential antidote for lewisite injury
    Kshirsagar, Sharvari
    Dandekar, Amruta
    Srivastava, Ritesh K.
    Khan, Jasim
    Muzaffar, Suhail
    Athar, Mohammad
    Banga, Ajay K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 647
  • [17] Microneedle-mediated transdermal delivery of FK506 for treatment of acute cardiac allograft rejection
    Deng, Cheng
    Wang, Chenyuan
    Fu, Wenpei
    Wu, Lujuan
    Jin, Qiaofeng
    Zhang, Li
    Zhang, Wen
    Li, Wei
    Xie, Mingxing
    MATERIALS & DESIGN, 2023, 235
  • [18] Layer-by-Layer Microneedle-Mediated rhEGF Transdermal Delivery for Enhanced Wound Epidermal Regeneration and Angiogenesis
    Yuan, Renqiang
    Yang, Ning
    Huang, Yueru
    Li, Weikun
    Zeng, Yi
    Liu, Zonghao
    Tan, Xin
    Feng, Fang
    Zhang, Qianli
    Su, Shao
    Chu, Cuilin
    Liu, Ling
    Ge, Liqin
    ACS APPLIED MATERIALS & INTERFACES, 2023, 15 (18) : 21929 - 21940
  • [19] Hybrid Microneedle-Mediated Transdermal Delivery of Atorvastatin Calcium-Loaded Polymeric Micelles for Hyperlipidemia Therapy
    Yang, Ming Wen Ou
    Hu, Liu Fu
    Feng, Yun Hao
    Li, Xiaobin
    Peng, Juan
    Yu, Ruixing
    Zhang, Can Yang
    Chen, Bo Zhi
    Guo, Xin Dong
    ACS APPLIED BIO MATERIALS, 2024, 7 (06): : 4051 - 4061
  • [20] Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment
    Ruan, Shuyao
    Li, Jiaqi
    Ruan, Hang
    Xia, Qing
    Hou, Xiaolin
    Wang, Zhi
    Guo, Teng
    Zhu, Chunyun
    Feng, Nianping
    Zhang, Yongtai
    JOURNAL OF CONTROLLED RELEASE, 2024, 366 : 712 - 731